Lasa Supergenerics Ltd - 540702 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
In accordance with the Regulation 44 (3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the details of voting results of the 4th Annual General Meeting (AGM) of the Company held on Friday, September 27, 2019 at 09:00 am (IST) at the Registered Office of the Company C-105, MIDC Mahad, Raigad, Maharashtra - 402309. Lasa Supergenerics Ltd - 540702 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 4th Annual General Meeting (AGM) of the Members of the Company held on September 27, 2019. Pursuant to Regulation 30 read with Part A of Schedule III SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are pleased to provide hereunder the proceedings of 4th Annual General Meeting (AGM) of the Company, held on Friday, September 27, 2019 at the Registered Office of the Company C-105, MIDC Mahad, Dist- Raigad, Mahad - 402 309. The Meeting commenced at 9.00 a.m. Lasa Supergenerics Ltd - 540702 - Draft Letter of Offer
Chartered Finance Management Ltd ("Manager to Open Offer") has submitted to BSE a copy of Draft Letter of Offer to the Public Equity Shareholders of Lasa Supergenerics Ltd ("Target Company"). Lasa Supergenerics Ltd - 540702 - Fixes Book Closure for AGM
Lasa Supergenerics Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 21, 2019 to September 27, 2019 (both days inclusive) for the purpose of 4th Annual General Meeting (AGM) of the Company to be held on September 27, 2019. Lasa Supergenerics Ltd - 540702 - Updates on Open Offer
Chartered Finance Management Ltd ("Manager to the Offer") has submitted to BSE a copy of Detailed Public Statement in terms of Regulation 15(2), read with Regulation 13(4) and Regulation 14(3) of SEBI (SAST) Regulations, 2011, as amended, to Public Equity Shareholders of Lasa Supergenerics Ltd ("Target Company"). Lasa Supergenerics Ltd - 540702 - Reg. 34 (1) Annual Report
Pursuant to regulation 34(1) of SEBI (Listing Obligation and Disclosure Requirement), 2015 please find enclosed herewith Annual Report 2018-19 of Lasa Supergenerics Limited for your reference and records. Lasa Supergenerics Ltd - 540702 - Updates on Open Offer (Revised)
With reference to the earlier Announcement regarding Public Announcement dated August 29, 2019 for Intimation of Open Offer, Chartered Finance Management Ltd ("Manager to the Offer") has now submitted to BSE a copy of Revised Public Announcement for the attention of Public Shareholders of Lasa Supergenerics Ltd ("Target Company"). Lasa Supergenerics Ltd - 540702 - Open Offer
Chartered Finance Management Ltd ("Manager to the Offer") has submitted to BSE a copy of Public Announcement for the attention of Public Shareholders of Lasa Supergenerics Ltd ("Target Company"). Lasa Supergenerics Ltd - 540702 - Outcome of Board Meeting
Outcome of Board Meeting held today i.e. 29 August, 2019 The Board of Directors at its meeting held today inter-alia considered and approved the following; 1) venue, date and time of 4th Annual General Meeting of the Company. 2) notice of 4th Annual General Meeting along with Directors Report for the financial year 2018-19. 3) appointment of Mr. Amit R. Dadheech, Practicing Company Secretary to act as a Scrutinizer for 4th Annual General Meeting of the company. 4) approved preferential allotment of upto 1,78,08,219 equity shares of the company as per ICDR Regulations to Promoter of the company i.e Dr Omkar Herlekar for consideration other than cash subject to shareholders approval in the ensuing general meeting and statutory approvals (if any). Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for Considering Matters As Mentioned In Earlier Notice Dated August 13, 2019.
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2019 ,inter alia, to consider and approve With reference to our earlier notice dated August 13, 2019 and August 17, 2019 we hereby inform you that Meeting of the Board of Directors of the Company is rescheduled on Thursday, August 29, 2019 at 11.00 a.m. (IST) at the Corporate Office address of the Company whereas the agenda remains unchanged.